Benzinga
Benzinga
Benzinga
martedì, settembre 22

Tiziana Life Sciences Ltd

TLSANASDAQ
Trade with Public
Trade with Public
$0.9046
-0.001-0.11%
In chiusura: Sep 18, 5:00 PM EST
$0.9430
0.03744.13%
Pre-mercato: 7:22 AM EST
PanoramicaNotiziePrevisioni utiliEventiObiettivi di prezzoDati finanziariSentimentAzionariatoConfrontaOpzioniRapporto azionario

Tiziana Life Sciences Financials

Tiziana Life Sciences (TLSA) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Avi Kapoor

Tiziana Life Sciences Ltd Reports Annual Results For The 12 Months Ended December 31, 2022, And Corporate Update; Tiziana Ended The Period With $18.1M Cash

2022 Year End Financial Results For the twelve months ended 31 December 2022 Tiziana reported a loss of $19.0 million compared to $27.9 million in the twelve months ended 31 December
Happy Mohamed

PRO
Tiziana Life Sciences 1H Net Loss $8.3M

Benzinga Newsdesk

PRO
UPDATE: Tiziana Sees Clinical Trial For Crohn's Disease Candidate In Q4'22

Benzinga Newsdesk

The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29)
Shanthi Rexaline

The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1)
Shanthi Rexaline

Dati e API: API Benzinga · API notizie azionarie · API valutazioni analisti · API logo aziende

Benzinga

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

© 2026 Benzinga | All Rights Reserved